Akorn, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Mar 5, 2019
  • Last warning letter 2012
Inspections 6 0 OAI
Recalls 192 0 Class I (0%)
Warning letters 1 Latest Oct 2, 2012
510(k) clearances 0 None on file

Akorn, Inc. has 192 FDA recalls, 6 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Akorn, Inc., the most recent on Oct 2, 2012. FDA has published 11 Form 483s for Akorn, Inc..

What these totals cover: FDA records filed under the name "Akorn, Inc." and its spelling variant "Akorn".

Latest recall
D-0793-2023 · Class II · Apr 26, 2023
Latest inspection
Mar 5, 2019 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls192Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections6Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Akorn, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Akorn, Inc.: FDA inspections per year

2017: 2 inspections (0 OAI), 0 warning letters, 7 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 12 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 15 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 7 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 7 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 37 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 87 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
2023000870
2022000370
202100070
202000070
2019100150
2018000120
201720070

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Akorn, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Akorn, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Akorn, Inc. FDA Warning Letters

1 warning letter on Oct 2, 2012.

IssuedSubjectIssuing officeClose-out letter
Oct 2, 2012 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

192 recall records from Aug 5, 2014 to Apr 26, 2023. Showing the 20 most recent. View all 192 recall records

NumberClassProductDate
D-0793-2023Class IICimetidine HCl Oral Solution 300mg/5mL, 237 mL bottles, Rx Only, Distributed by: Akorn Operating…Apr 26, 2023
D-0836-2023Class IIPrednisolone Oral Solution, USP, 15 mg/5 mL, packaged in a) 240 mL and b) 480 mL bottles, Rx Only…Apr 26, 2023
D-0781-2023Class IIAcetic Acid Otic Solution, 15 mL per bottle, Rx only, Distributed by: Akorn Operating Company LLC…Apr 26, 2023
D-0848-2023Class IISulfamethoxazole & Trimethoprim Oral Suspension USP, 200mg/40mg per 5mL, 473 mL bottles, Cherry…Apr 26, 2023
D-0800-2023Class IIDiuril (chlorothiazide sodium) Injection, 500mg/vial, Single-Dose Vial, Rx Only, Distributed by…Apr 26, 2023
D-0801-2023Class IIDOCU LIQUID (docusate sodium, 50 mg/5 mL), packaged in 473mL bottles and b)10mL Unit Dose cups…Apr 26, 2023
D-0839-2023Class IIProparacaine HCl Ophthalmic Solution, USP 0.5%, 15 mL bottles, Rx Only, Distributed by: Akorn…Apr 26, 2023
D-0796-2023Class IIClobetasol Propionate Shampoo, 0.05%, 4oz (118 mL) bottles, Rx Only, Distributed by: Akorn…Apr 26, 2023
D-0858-2023Class IICalcitriol Injection 2 mcg/mL, 1 mL ampules Rx Only, Distributed by: Akorn Operating Company, LLC…Apr 26, 2023
D-0859-2023Class IIMidazolam Injection, USP, 50 mg/10mL (5mg/mL), For Intramuscular or Intravenous Use Only, 10 mL…Apr 26, 2023
D-0813-2023Class IIKetorolac Tromethamine Ophthalmic Solution, 0.5%, Sterile, packaged in a) 3mL bottles, b bottles) 5…Apr 26, 2023
D-0806-2023Class IIGranisetron HCl Injection, USP, 1 mg/mL, packaged in a) 1mL and b) 4 mL vials, Rx Only, For…Apr 26, 2023
D-0803-2023Class IIFerrous Sulfate Iron Supplement Drops, packaged in 50 mL bottles, Distributed by: Akorn Operating…Apr 26, 2023
D-0789-2023Class IICalcipotriene Topical Solution, 0.005% (Scalp Solution), 60 mL bottles, Rx Only, Distributed by…Apr 26, 2023
D-0817-2023Class IILevocarnitine Oral Solution, USP, 118 mL bottles, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL…Apr 26, 2023
D-0862-2023Class IIPilocarpine Hydrochloride Ophthalmic Solution, USP 4%, 15 mL bottles, Rx Only, Sterile, Distributed…Apr 26, 2023
D-0840-2023Class IIRifampin Capsules USP, 150 mg, 30-count bottles, Rx Only, Sterile, Distributed by: Akorn Operating…Apr 26, 2023
D-0833-2023Class IIOlopatadine HCl Ophthalmic Solution, USP, 0.1%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc…Apr 26, 2023
D-0820-2023Class IILevofloxacin Ophthalmic Solution, 0.5%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc., Lake…Apr 26, 2023
D-0860-2023Class IIOlopatadine HCl Ophthalmic Solution, USP, 0.2%, 5mL bottles, Rx Only, Sterile, Manufactured by…Apr 26, 2023

Recent FDA inspections

6 inspections from Nov 10, 2009 to Mar 5, 2019.

DateSiteProductClassificationFEI
Mar 5, 2019Gurnee, ILDrugsNo Action Indicated (NAI)3003102962
Mar 20, 2017Gurnee, ILDrugsNo Action Indicated (NAI)3003102962
Feb 13, 2017Gurnee, ILDrugsNo Action Indicated (NAI)3003102962
Dec 18, 2015Gurnee, ILDrugsNo Action Indicated (NAI)3003102962
Nov 10, 2015Vernon Hills, ILDrugsNo Action Indicated (NAI)3008883167
Nov 10, 2009Gurnee, ILDrugsVoluntary Action Indicated (VAI)3003102962
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Akorn, Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Oct 2, 2012.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3003102962Gurnee, IL5Mar 5, 2019
FEI 3008883167Vernon Hills, IL1Nov 10, 2015

Akorn, Inc. and the FDA: common questions

Has Akorn, Inc. received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Akorn, Inc.. The most recent is dated Oct 2, 2012.

Has Akorn, Inc. received an FDA Form 483?

FDA has published 11 Form 483s for Akorn, Inc. in its reading room, the most recent dated Aug 30, 2018. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Akorn, Inc.?

The most recent FDA inspection on file ended Mar 5, 2019 at Gurnee, IL and was classified NAI. FDA has 6 inspections of Akorn, Inc. on file.

Has Akorn, Inc. had an FDA recall?

Yes. Akorn, Inc. has 192 FDA recalls on record. The most recent started Apr 26, 2023.

Need more than this page shows? Ask about Akorn, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.